Strategic Acquisition Injeq has recently been involved in a high-profile acquisition by Flat Medical, signaling potential integration opportunities, partner alignment, and expanded distribution channels for the IQ-Tip system in the US and EU markets.

FDA Breakthrough The IQ-Tip device received FDA Breakthrough Device designation, highlighting it as a high-potential technology with competitive differentiation and a faster path to market adoption in healthcare facilities.

Regulatory Readiness Product development aligns with MDR 2017/745 and EN ISO 13485:2016, indicating strong regulatory posture and readiness for hospital procurement cycles, quality assurance, and risk management practices that buyers value.

Clinical Validation Three university hospital investigations support clinical performance and safety for demanding lumbar punctures across age groups, providing credible references for adoption pitches to clinicians and procurement teams.

Market Positioning Target customers include hospitals and clinics performing lumbar punctures and injections; the breakthrough device status and potential post-merger expansion suggest scalable deployment opportunities through health systems and medical device distributors.